Centene (NYSE: CNC)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-26 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.680 | 1.830 | 0.1500 | ||||
REV | 34.500B | 37.185B | 2.685B |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Centene (NYSE: CNC) through any online brokerage.
Other companies in Centene’s space includes: Humana (NYSE:HUM), HealthEquity (NASDAQ:HQY), Tekla World Healthcare (NYSE:THW), Molina Healthcare (NYSE:MOH) and Progyny (NASDAQ:PGNY).
The latest price target for Centene (NYSE: CNC) was reported by Morgan Stanley on Thursday, June 23, 2022. The analyst firm set a price target for 103.00 expecting CNC to rise to within 12 months (a possible 19.56% upside). 24 analyst firms have reported ratings in the last year.
The stock price for Centene (NYSE: CNC) is $86.15 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Centene.
Centene’s Q2 earnings are confirmed for Tuesday, July 26, 2022.
There is no upcoming split for Centene.
Centene is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.